LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
9.29
-0.47 (-4.82%)
Apr 28, 2026, 4:00 PM EDT - Market closed
LENZ Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 291 | 501 | 794 | - | - | - |
| Market Cap Growth | -47.80% | -36.94% | - | - | - | - |
| Enterprise Value | -0 | 299 | 578 | - | - | - |
| Last Close Price | 9.29 | 16.00 | 28.87 | - | - | - |
| PS Ratio | 15.26 | 26.23 | - | - | - | - |
| PB Ratio | 1.02 | 1.76 | 3.89 | - | - | - |
| P/TBV Ratio | 1.02 | 1.76 | 3.89 | - | - | - |
| EV/Sales Ratio | - | 15.69 | - | - | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | - |
| Net Debt / Equity Ratio | -1.02 | -1.02 | -1.02 | -1.27 | -1.19 | -1.07 |
| Net Debt / EBITDA Ratio | 3.21 | 3.21 | 3.55 | 0.90 | 4.22 | 2.74 |
| Net Debt / FCF Ratio | 4.17 | 4.17 | 3.47 | 1.08 | 10.71 | 3.39 |
| Asset Turnover | 0.07 | 0.07 | - | - | 0.46 | - |
| Quick Ratio | 13.91 | 13.91 | 20.19 | 3.55 | 4.68 | 14.61 |
| Current Ratio | 14.23 | 14.23 | 20.36 | 3.63 | 4.91 | 14.62 |
| Return on Equity (ROE) | -33.63% | -33.63% | -38.94% | -157.61% | -39.80% | - |
| Return on Assets (ROA) | -21.86% | -21.86% | -25.64% | -77.17% | -20.07% | - |
| Return on Capital Employed (ROCE) | -32.00% | -32.00% | -28.60% | -139.70% | -28.00% | -39.20% |
| Earnings Yield | -28.19% | -16.40% | -6.27% | - | - | - |
| FCF Yield | -24.03% | -13.98% | -7.54% | - | - | - |
| Buyback Yield / Dilution | -35.39% | -35.39% | -986.27% | 79.28% | -1.05% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.